Healthcare provider profile · identity verified

Brian Joseph Boyle, M.D.

Family Practice · DUBLIN, OH · NPI 1770505992

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	527	146
Levothyroxine Sodium	Levothyroxine Sodium	365	91
Losartan Potassium	Losartan Potassium	352	105
Amlodipine Besylate	Amlodipine Besylate	341	101
Pantoprazole Sodium	Pantoprazole Sodium	213	64
Gabapentin	Gabapentin	206	45
Lisinopril	Lisinopril	206	59
Escitalopram Oxalate	Escitalopram Oxalate	179	48
Metoprolol Succinate	Metoprolol Succinate	171	48
Metformin Hcl	Metformin Hcl	167	44
Trazodone Hcl	Trazodone Hcl	149	41
Alprazolam	Alprazolam	138	41
Azithromycin	Azithromycin	138	95
Tamsulosin Hcl	Tamsulosin Hcl	136	34
Prednisone	Prednisone	134	101
Simvastatin	Simvastatin	133	39
Valsartan	Valsartan	130	38
Eliquis	Apixaban	128	26
Montelukast Sodium	Montelukast Sodium	115	33
Tramadol Hcl	Tramadol Hcl	114	24
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	108	66
Omeprazole	Omeprazole	107	35
Rosuvastatin Calcium	Rosuvastatin Calcium	107	36
Furosemide	Furosemide	98	35
Sertraline Hcl	Sertraline Hcl	94	27
Albuterol Sulfate Hfa	Albuterol Sulfate	93	28
Ozempic	Semaglutide	90	15
Citalopram Hbr	Citalopram Hydrobromide	89	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	89	26
Hydrochlorothiazide	Hydrochlorothiazide	88	27
Metformin Hcl Er	Metformin Hcl	87	22
Allopurinol	Allopurinol	84	25
Pravastatin Sodium	Pravastatin Sodium	81	26
Bupropion Xl	Bupropion Hcl	80	19
Buspirone Hcl	Buspirone Hcl	77	16
Meloxicam	Meloxicam	76	22
Carvedilol	Carvedilol	71	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	68	20
Metoprolol Tartrate	Metoprolol Tartrate	68	23
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	67	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	16
Duloxetine Hcl	Duloxetine Hcl	61	14
Clopidogrel	Clopidogrel Bisulfate	59	17
Doxycycline Hyclate	Doxycycline Hyclate	57	39
Lorazepam	Lorazepam	57	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	57	19
Synthroid	Levothyroxine Sodium	56	13
Glimepiride	Glimepiride	54	18
Fluconazole	Fluconazole	44	14
Fluticasone Propionate	Fluticasone Propionate	43	17
Acyclovir	Acyclovir	42	suppressed
Atenolol	Atenolol	42	suppressed
Ondansetron Odt	Ondansetron	42	17
Cefuroxime	Cefuroxime Axetil	41	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	12
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Potassium Chloride	Potassium Chloride	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Cephalexin	Cephalexin	34	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	12
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Methylprednisolone	Methylprednisolone	33	29
Mometasone Furoate	Mometasone Furoate	32	19
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	19
Finasteride	Finasteride	30	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	30	29
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	23
Lidocaine	Lidocaine	28	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	28	suppressed
Amoxicillin	Amoxicillin	27	16
Xarelto	Rivaroxaban	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Meclizine Hcl	Meclizine Hcl	25	15
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	19
Premarin	Estrogens, Conjugated	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Leflunomide	Leflunomide	21	suppressed
Telmisartan	Telmisartan	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Famotidine	Famotidine	18	suppressed
Mupirocin	Mupirocin	18	18
Nystatin	Nystatin	18	12
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Gemtesa	Vibegron	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	14	12
Sotalol	Sotalol Hcl	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Ibu	Ibuprofen	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error